genuine question about dose escalation that I am slightly embarrassed to ask
Genuinely asking, not being difficult.
Everyone in c/glp1uk repeats that dose escalation is important. I believe it, but I have never seen anyone show why, and when I search I get 22 threads of people agreeing with each other.
Is there a paper? Is there a measurement? Or is this one of those things that is true because it has been repeated since 2023?
I am not trying to be the "source?" guy. I would just like a source.
best — the order this archive was captured in
Not convinced. The evidence does not support that reading.
heart rate and dose escalation need actual measurements, not impressions
Retitled to remove editorialising. Put the evidence in the body.
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
TRIUMPH data is phase 2, not phase 3, smaller n and shorter
[removed by moderator]
Strongly agree. Heart rate escalation needs the actual data, not impressions.
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual
That is net peptide content, not purity. Different number, different meaning.
- 1TRIUMPH data is phase 2, not phase 3, smaller n and shorter6 comments in this branch · started by u/mateusz_mensah